chr2-108765037-G-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_006267.5(RANBP2):​c.4498G>C​(p.Ala1500Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,613,790 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 2 hom. )

Consequence

RANBP2
NM_006267.5 missense

Scores

1
18

Clinical Significance

Likely benign criteria provided, single submitter U:1B:3

Conservation

PhyloP100: 0.0640

Publications

3 publications found
Variant links:
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007832438).
BP6
Variant 2-108765037-G-C is Benign according to our data. Variant chr2-108765037-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 469460.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 183 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP2NM_006267.5 linkc.4498G>C p.Ala1500Pro missense_variant Exon 20 of 29 ENST00000283195.11 NP_006258.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP2ENST00000283195.11 linkc.4498G>C p.Ala1500Pro missense_variant Exon 20 of 29 1 NM_006267.5 ENSP00000283195.6
RANBP2ENST00000697737.1 linkc.2602+6489G>C intron_variant Intron 18 of 26 ENSP00000513426.1
RANBP2ENST00000697740.1 linkc.2524+6489G>C intron_variant Intron 18 of 26 ENSP00000513427.1

Frequencies

GnomAD3 genomes
AF:
0.00120
AC:
182
AN:
151914
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00416
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000402
AC:
101
AN:
251022
AF XY:
0.000265
show subpopulations
Gnomad AFR exome
AF:
0.00381
Gnomad AMR exome
AF:
0.000984
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000119
AC:
174
AN:
1461756
Hom.:
2
Cov.:
36
AF XY:
0.000103
AC XY:
75
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.00305
AC:
102
AN:
33462
American (AMR)
AF:
0.000984
AC:
44
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000809
AC:
9
AN:
1111932
Other (OTH)
AF:
0.000199
AC:
12
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00120
AC:
183
AN:
152034
Hom.:
0
Cov.:
32
AF XY:
0.00117
AC XY:
87
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.00417
AC:
173
AN:
41494
American (AMR)
AF:
0.000524
AC:
8
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67962
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000236
Hom.:
0
Bravo
AF:
0.00137
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000420
AC:
51
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

RANBP2-related disorder Uncertain:1
Jan 11, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The RANBP2 c.4498G>C variant is predicted to result in the amino acid substitution p.Ala1500Pro. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.41% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Familial acute necrotizing encephalopathy Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.32
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.21
T
M_CAP
Benign
0.038
D
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.064
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.043
Sift
Benign
0.038
D
Sift4G
Benign
0.068
T
Polyphen
0.60
P
Vest4
0.15
MVP
0.41
MPC
1.1
ClinPred
0.021
T
GERP RS
2.4
Varity_R
0.13
gMVP
0.34
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145284139; hg19: chr2-109381493; API